Paragon wins $5M Army contract for Ebola vaccine
October 26, 2010 - www.bizjournals.com
Paragon Bioservices won a contract worth nearly $5 million to help the U.S. Army develop a vaccine for Ebola viruses.
The Baltimore-based research and manufacturer will work with the U.S. Army Medical Research Institute for Infectious Diseases to develop and produce vaccines against Ebola Zaire, Ebola Sudan and Marburg viruses and test the effectiveness of these vaccines.
Ebola and Marburg are serious viruses that can cause a hemorrhagic fever and have up to a 90 percent fatality rate in humans. Currently, there are no known vaccines or therapies available for these viruses.
They are commonly spread through blood and bodily fluids of infected patients. The viruses have been considered potential threats in biologocial warfare or terrorism since both are infectious by aerosol, or airborne particles.
Paragon, which has its main office at the University of Maryland BioPark, focuses on research, process development and manufacturing of biologics.